NicholasAlexanderVitanzaMD

Pediatric Hematology & Oncology • Seattle, WA

Pediatric Neuro-Oncology

Pediatric Neuro-Oncologist and Translational Scientist at Seattle Children's

Join to view full profile

Dr. Vitanza is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vitanza's full profile

Already have an account?

Office
4800 Sand Point Way NE
# MB8
Seattle, WA 98105
Phone+1 845-559-3679

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Neuro-Oncology, 2014 - 2016
NYU Grossman School of MedicineFellowship, Pediatric Hematology/Oncology, 2011 - 2014
Stony Brook Medicine/University HospitalResidency, Pediatrics, 2008 - 2011
American University of the Caribbean School of MedicineClass of 2008

Certifications & Licensure

CA State Medical License 2014 - Present
ID State Medical License 2021 - 2025
WA State Medical License 2016 - 2025
AK State Medical License 2021 - 2022
NY State Medical License 2011 - 2019
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Young Investigator Travel Stipend Award American Society of Pediatric Hematology/Oncology, 2014
Research Training Award for Fellows American Society of Hematology, 2013

Clinical Trials

ONC201 in Pediatric H3 K27M Gliomas Start of enrollment: 2018 Jan 29
Active, not recruiting
Phase 1
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors Start of enrollment: 2018 Jul 26
Active, not recruiting
Phase 1

Publications & Presentations

PubMed

32 citations
Tumor inflammation-associated neurotoxicity.
Jasia Mahdi, Jorg Dietrich, Karin Straathof, Claire Roddie, Brian J Scott
Nature Medicine. 2023-04-01
155 citations
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
Nicholas A Vitanza, Adam Johnson, Ashley Wilson, Christopher Brown, Jason K. Yokoyama
Nature Medicine. 2021-07-12
53 citations
EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastoma.
Ali C. Ravanpay, Juliane Gust, Adam Johnson, Lisa S. Rolczynski, Michelle Cecchini
Oncotarget. 2019-12-17

Press Mentions

Novel Approaches to Malignant Brain Tumor Treatment Aim to Overcome Familiar ChallengesJanuary 27th, 2022
AeroPress Grants Cancer Research Award to Dr. Nicholas VitanzaMarch 24th, 2021
First Patient Treated with Experimental Therapy for Deadly Childhood Brain CancerNovember 5th, 2020
Join now to see all

Grant Support

Research Training Award for FellowsAmerican Society of Hematology2013–2014